Literature DB >> 7666202

NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1.

G Z Yan1, E B Ziff.   

Abstract

We have examined the effects of NGF on components of the PC12 cell cycle machinery. We show that NGF represses over 6-8 d the levels of specific cdk kinase proteins and the G2-M phase specific cyclin B1 and the S phase marker PCNA as well as the level of phosphorylation of the retinoblastoma (Rb) protein. All of these changes may provide a basis for a NGF block to cell cycling. Unexpectedly, the G1 phase-specific cyclin D1 was dramatically increased by inducers of differentiation (NGF and FGF), but not by inducers of proliferation (EGF and insulin). Although the levels of cyclin D1/cdk2 and cyclin D1/cdk4 complexes increased following NGF treatment, as did cyclin D1/Rb complexes, the associated kinase activities declined, indicating that NGF also induces an inhibitor of cdk kinase activity. In agreement, NGF induced the cdk inhibitory protein, p21, which was found in cyclin D1/cdk kinase complexes after NGF treatment. We show that vector over expression of cyclin D1 in PC12 is sufficient on its own to arrest the cells in G1 phase and inhibit expression of PCNA. These results indicate that NGF induction of cyclin D1 and inactivation of cdk kinases, the latter possibly by increase of p21, play a central role in the NGF block of PC12 cell cycling.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666202      PMCID: PMC6577654     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells.

Authors:  G E Aranda-Abreu; L Behar; S Chung; H Furneaux; I Ginzburg
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression.

Authors:  F Beier; Z Ali; D Mok; A C Taylor; T Leask; C Albanese; R G Pestell; P LuValle
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

Review 3.  Nucleoside diphosphate kinases in mammalian signal transduction systems: recent development and perspective.

Authors:  Narimichi Kimura; Nobuko Shimada; Yasushi Ishijima; Mitsugu Fukuda; Yohko Takagi; Naoshi Ishikawa
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

4.  The induction of serine/threonine protein phosphorylations by a PDGFR/TrkA chimera in stably transfected PC12 cells.

Authors:  Jordane Biarc; Robert J Chalkley; A L Burlingame; Ralph A Bradshaw
Journal:  Mol Cell Proteomics       Date:  2011-10-25       Impact factor: 5.911

5.  Autoregulation of Musashi1 mRNA translation during Xenopus oocyte maturation.

Authors:  Karthik Arumugam; Melanie C Macnicol; Angus M Macnicol
Journal:  Mol Reprod Dev       Date:  2012-07-09       Impact factor: 2.609

6.  Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor.

Authors:  K Ye; D A Compton; M M Lai; L D Walensky; S H Snyder
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

7.  Role of cyclins in neuronal differentiation of immortalized hippocampal cells.

Authors:  W Xiong; R Pestell; M R Rosner
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

8.  Ebp1 isoforms distinctively regulate cell survival and differentiation.

Authors:  Zhixue Liu; Jee-Yin Ahn; Xia Liu; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

Review 9.  A Bex-cycle built for two.

Authors:  Bruce D Carter
Journal:  EMBO Rep       Date:  2006-04       Impact factor: 8.807

10.  Cell cycle phase-specific surface expression of nerve growth factor receptors TrkA and p75(NTR).

Authors:  J L Urdiales; E Becker; M Andrieu; A Thomas; J Jullien; L A van Grunsven; S Menut; G I Evan; D Martín-Zanca; B B Rudkin
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.